Skip to content

K-V Pharmaceutical, Orphan Drug Makena, And Hologic (December 11, 2012 Update)

December 11, 2012

       A deal was struck last week, with K-V Pharmaceutical agreeing to pay Hologic Inc $60 million to settle a $95 million claim Hologic files in bankruptcy court over the rights, title, and interest for orphan drug Makena – per a recent 8-K SEC filing. Makena was sold to Hologic in.     

         The $60 million settlement deal is dependent on K-V Pharmaceutical getting a debtor-in-possession financing (DIP) by December 31, 2012, and funding from a lender to keep the company operations going.  The settlement agreement is awaiting bankruptcy approval.      


 Blog December 7, 2012 Post titled, “Latest (December 6, 2012) News On K-V Pharmaceutical and Orphan Drug Makena” December 11, 2012 article titled, “KV, Hologic reach $60M deal on Makena”  

St. Louis Business Journal December 11, 2012 article titled, “KV to pay Hologic $60 million to settle Makena drug dispute “  

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: